Acute disseminated encephalomyelitis secondary prevention
|
Acute disseminated encephalomyelitis Microchapters |
|
Differentiating Acute disseminated encephalomyelitis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Acute disseminated encephalomyelitis secondary prevention On the Web |
|
American Roentgen Ray Society Images of Acute disseminated encephalomyelitis secondary prevention |
|
FDA on Acute disseminated encephalomyelitis secondary prevention |
|
CDC on Acute disseminated encephalomyelitis secondary prevention |
|
Acute disseminated encephalomyelitis secondary prevention in the news |
|
Blogs on Acute disseminated encephalomyelitis secondary prevention |
|
Directions to Hospitals Treating Acute disseminated encephalomyelitis |
|
Risk calculators and risk factors for Acute disseminated encephalomyelitis secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Case reports and literature reviews have highlighted the importance of early MRI scans of the brain as a guide for immediate intervention for ADEM.Plasmapheresis should be considered early in the disease course for severe or life-threatening cases of ADEM.
Secondary Prevention
Early diagnostic MRI of the brain[1]
Case reports and literature reviews have highlighted the importance of early MRI scans of the brain as a guide for immediate intervention for ADEM. Despite a high level of clinical suspicion and abundance of adequate treatment options, MRI is often delayed till the appearance of significant mortality and morbidity. Primary care physicians should be especially aware of its importance in ADEM.
Plasmapheresis
It should be considered early in the disease course for severe or life-threatening cases of ADEM[2].
References
- ↑ Okun MS, Millar B, Watson R (2000). "Early diagnostic magnetic resonance imaging in acute disseminated encephalomyelitis". South Med J. 93 (8): 793–6. PMID 10963511.
- ↑ Pohl D, Tenembaum S (2012). "Treatment of acute disseminated encephalomyelitis". Curr Treat Options Neurol. 14 (3): 264–75. doi:10.1007/s11940-012-0170-0. PMID 22476745.